Don't be Late! Postponing Cognitive Decline and Preventing Early Unemployment in People With Multiple Sclerosis

Recruiting N/A Interventional Study
Multiple Sclerosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 67
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
270 (estimated)
Sponsor
Amsterdam UMC, location VUmc · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this randomized controlled trial is to compare the effectiveness of two innovative interventions aimed at preventing cognitive decline and work-related problems to enhanced usual care in improving quality of life in people with multiple sclerosis. Secondary objectives are: * to compare the effectiveness of the investigated interventions in improving cognitive, psychological, and work …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Confirmed MS diagnosis according to the McDonald 2017 criteria * Age between 18 and 67 * No changes in disease modifying therapy prior to inclusion (i.e., no changes in last 3 months) - this criterion only applies at inclusion to ensure participants are in a stable situation a…
Contacts

Jip Aarts

+31 71 5275081

j.aarts@fsw.leidenuniv.nl

CONTACT

Shalina Saddal

+31 20 566 38 01

s.saddal@amsterdamumc.nl

CONTACT